PRME · Prime Medicine, Inc. · Proposed Sales
$3.90
-0.02 (-0.51%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, we concluded that substantial doubt exists about our ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$711.00M
Shares
181.38M
Volume · Oct 20
3.69M
Avg daily vol (3M)
3.49M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2023-06-20 | Alphabet Holdings LLC | 10% Stockholder | 522,561 | 2023-06-20 | Raymond James & Associates, Inc. |
| 2023-06-12 | Alphabet Holdings LLC | 10% Stockholder | 159,596 | 2023-06-12 | RAYMOND JAMES & ASSOCIATES |
| 2023-06-05 | Alphabet Holdings LLC | 10% Stockholder | 88,081 | 2023-06-05 | Raymond James & Associates, Inc. |
| 2023-05-30 | Alphabet Holdings LLC | 10% Stockholder | 71,263 | 2023-05-30 | Raymond James & Associates |
| 2023-05-18 | Alphabet Holdings LLC | 10% Stockholder | 260,156 | 2023-05-18 | RAYMOND JAMES & ASSOCIATES INC |
| 2023-05-08 | GV 2019, L.P. | 10% Stockholder | 1,121,197 | 2023-05-08 | RAYMOND JAMES & ASSOCIATES INC |
Showing 1–6 of 6 filings
Key facts
CIK
1894562
CUSIP
74168J101
13F (30d)
14 filings
14 filers
Visit website
Investor relations